Request a potential collaboration with contract research organization specialized in inhalation therapy development

ADA is a startup developing nanomedicine-based inhaled therapies for the treatments of chronic respiratory diseases. Its development requires a partnership with a contract research organization which possesses both the strategic expertise for the most cost efficient regulatory path and the right contacts with the laboratories that operate in good laboratory practices as well as the contacts with the manufactures for the identification of the right device to develop our nanomedidicine-based inhaled therapy. Based on the results of the studies we are currently conducting we would like to develop an inhalation powder to acquire pharmacokinetic data that will anticipate the conditions to then enter the first-in-human studies.